CD5 POSITIVE

Clinical trials for CD5 POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CD5 POSITIVE trials appear

Sign up with your email to follow new studies for CD5 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Common arthritis drug may boost fight against tough lymphoma

Disease control Not yet recruiting

This study is testing if adding the anti-inflammatory drug celecoxib to the standard chemotherapy regimen (R-CHOP) works better for patients newly diagnosed with an aggressive form of lymphoma called CD5-positive DLBCL. It will involve 60 patients who will be randomly assigned to…

Matched conditions: CD5 POSITIVE

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

CD5 POSITIVE

Get alerted when new CD5 POSITIVE trials appear

Common arthritis drug may boost fight against tough lymphoma